JUL 30, 2018 3:29 PM PDT

Therapeutic Created for a Rare Genetic Disease

WRITTEN BY: Carmen Leitch

There is new hope for people that suffer from a rare genetic disease called Hereditary angioedema (HAE). It causes painful swelling in the mucous membranes and skin, as well as problems in the gastrointestinal tract and airways; patients have a poor quality of life unless they receive adequate treatment. A new drug has been developed that can prevent the swelling flares that are a hallmark of HAE, and an international study investigated its efficacy. The positive results have been published in the New England Journal of Medicine and are outlined in the video.

Reporting from over 26 universities throughout the world, researchers found that the drug can dramatically improve everyday life for HAE patients, who otherwise can suffer painful swelling several times a week. It can also be easily ingested in a capsule.

"Hereditary angioedema is a condition that may be associated with lifelong impairment. With this fundamentally new development, we may reduce HAE attacks and consistently improve our patients' quality of life," said Dr. Emel Aygören-Pürsün. As an internal medicine specialist in the Division of Oncology, Hematology and Hemostaseology at the Department for Children and Adolescents of the University Hospital Frankfurt, Aygören-Pürsün was the principal investigator of this study.

In most patients, HAE traces back to a genetic error they were born with. That mutation causes a protein called C1-inhibitor to be dysfunctional, which increases the levels of a peptide called bradykinin. That can, in turn, increase the permeability of tiny blood vessels.
 
HAE swelling attacks used to be preventable only with an injection; while tablets were available, they didn't work or led to bad side effects. So, the creation of a capsule that works is a major breakthrough for patients.

Swelling in a hand caused by hereditary angioedema. / Credit: Emel Aygören-Pürsün

 The new therapeutic is a small synthetic molecule currently named BCX7353. It inhibits kallikrein, which would otherwise generate more bradykinin (and increase blood vessel leakage). Patients will be able to conveniently prevent attacks without suffering side effects. 

After assessing how the drug or a placebo worked in 77 patients, the researchers found that a daily dose of 125 mg or more significantly reduced angioedema attacks. In those taking over 125 mg daily, the frequency of attacks was reduced by 70 percent over placebo. Forty percent of those patients had no attacks during the trial. Thus, quality of life was improved, and side effects were mild, indicating that BCX7353 should be tested further so the FDA can approve it for long-term use.


Sources: AAAS/Eurekalert! Via Goethe University Frankfurt, NEJM

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 22, 2020
Cell & Molecular Biology
What is ChIP-Seq and Is It Quantitative After All?
NOV 22, 2020
What is ChIP-Seq and Is It Quantitative After All?
ChIP-Seq is a tool for analyzing the interactions between DNA and the proteins that bind to it, which influences gene ac ...
NOV 27, 2020
Cell & Molecular Biology
UVC Rays May be a Bigger Cancer Risk Than Known
NOV 27, 2020
UVC Rays May be a Bigger Cancer Risk Than Known
The sun emits different kinds of light and rays including visible and ultraviolet (UV) and infrared. Some of those forms ...
NOV 27, 2020
Genetics & Genomics
Gravity Affects Gene Expression
NOV 27, 2020
Gravity Affects Gene Expression
If people are going to explore deep space, we should learn more about the effects that such an environment would potenti ...
JAN 01, 2021
Genetics & Genomics
Common Brain Disorder Has a Genetic Influence
JAN 01, 2021
Common Brain Disorder Has a Genetic Influence
It's thought that as many as one in one hundred people are born with a brain disorder known as Chiari 1 malformation, bu ...
JAN 10, 2021
Genetics & Genomics
Did Sleep Precede the Brain?
JAN 10, 2021
Did Sleep Precede the Brain?
The longer we stay awake without sleeping, the more difficult it can become to think straight. But our functioning is re ...
FEB 16, 2021
Cell & Molecular Biology
A Change in One Gene Might've Made Our Brains Uniquely Human
FEB 16, 2021
A Change in One Gene Might've Made Our Brains Uniquely Human
Stem cells can be used to create simplified versions of human organs called organoids, enabling researchers to study how ...
Loading Comments...